137 | IBRUTINIB ADDED TO MCL TREATMENT HAS STRONG IMPACT ON MRD RESPONSE AND DISEASE KINETICS: RESULTS FROM THE TRIANGLE TRIAL

Mouhamad Khouja, Christiane Pott, Simone Ferrero et al.|Hematological Oncology|2025

Cited by 1